Advanced Search

Technical Analysis for ADAG - Adagene Inc.

Grade Last Price % Change Price Change
B 20.07 -2.95% -0.61
ADAG closed down 2.95 percent on Friday, July 23, 2021, on 5.1 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical ADAG trend table...
Date Alert Name Type % Chg
Volume Surge Other 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -2.95%
Multiple of Ten Bullish Other -2.95%
Wide Bands Range Expansion -2.95%
Overbought Stochastic Strength -2.95%
Up 3 Days in a Row Strength -2.95%
Up 4 Days in a Row Strength -2.95%
Older End-of-Day Signals for ADAG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 5 days ago
Down 2 % 5 days ago
Down 1% 5 days ago
Up 3% 5 days ago
Up 2% 5 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Artificial Intelligence Immunotherapy Antibodies Health Care Cancer Immunotherapy Virotherapy Antibody Immunotherapies

Is ADAG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 22 Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors
Jul 22 Merck and Adagene ink trial collaboration and supply agreement
Jul 22 Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
Jul 13 China’s U.S. IPO Queue to Shrink Amid Regulatory Crackdown
Jul 9 20 Chinese Companies Listed on NYSE/NASDAQ/AMEX
Jul 7 Adagene announces $20M share repurchase program
Jul 7 Adagene Announces Authorization of Share Repurchase Program up to US$20 Million
Jun 16 Top Chinese Companies on NASDAQ
Jun 16 Adagene to be included in FTSE Russell Indexes
Jun 16 Adagene Announces Inclusion in FTSE Russell Indexes
See more ADAG news...

Indicators

Indicator Value
52 Week High 31.83
52 Week Low 11.2
Average Volume 33,876
200-Day Moving Average 0.00
50-Day Moving Average 14.51
20-Day Moving Average 16.10
10-Day Moving Average 18.46
Average True Range 1.14
ADX 40.22
+DI 36.75
-DI 6.30
Chandelier Exit (Long, 3 ATRs) 17.57
Chandelier Exit (Short, 3 ATRs) 16.08
Upper Bollinger Bands 21.34
Lower Bollinger Band 10.87
Percent B (%b) 0.88
BandWidth 65.03
MACD Line 1.65
MACD Signal Line 1.12
MACD Histogram 0.5303
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.88
Resistance 3 (R3) 22.80 21.80 22.41
Resistance 2 (R2) 21.80 21.08 21.83 22.25
Resistance 1 (R1) 20.93 20.64 20.43 21.01 22.10
Pivot Point 19.93 19.93 19.68 19.96 19.93
Support 1 (S1) 19.06 19.21 18.56 19.14 18.04
Support 2 (S2) 18.06 18.77 18.09 17.89
Support 3 (S3) 17.19 18.06 17.73
Support 4 (S4) 17.27